Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Annual fiscal-year EPS history; the page headline uses the current trailing EPS value. Historical series through 2025-12-31.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-3.23
EARNINGS PER SHARE (EPS) AVG 3Y
-2.68
EARNINGS PER SHARE (EPS) AVG 5Y
-2.37
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Boundless Bio, Inc.
Market Cap
$57.98M
Earnings Per Share (EPS)
N/A
TTM Avg
-3.23
3Y Avg
-2.68
5Y Avg
-2.37
Market Cap
$57.88M
Earnings Per Share (EPS)
-0.64
TTM Avg
-0.89
3Y Avg
-1.15
5Y Avg
-1.02
Market Cap
$58.13M
Earnings Per Share (EPS)
-0.32
TTM Avg
-0.42
3Y Avg
0.90
5Y Avg
-1.96
Market Cap
$58.94M
Earnings Per Share (EPS)
-2.39
TTM Avg
-2.92
3Y Avg
-5.17
5Y Avg
-5.77
Market Cap
$57.69M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.64
3Y Avg
-4.21
5Y Avg
-9.38
Market Cap
$58.97M
Earnings Per Share (EPS)
N/A
TTM Avg
-19.12
3Y Avg
-29.60
5Y Avg
-38.42
Market Cap
$60.02M
Earnings Per Share (EPS)
-13.20
TTM Avg
-15.24
3Y Avg
-17.58
5Y Avg
-15.68
Market Cap
$60.05M
Earnings Per Share (EPS)
-0.27
TTM Avg
-0.26
3Y Avg
-0.31
5Y Avg
-0.32
Market Cap
$56.02M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.18
3Y Avg
-0.24
5Y Avg
-0.27
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | $57.98M | N/A | -3.23 | -2.68 | -2.37 |
| PDS Biotechnology Corporation (PDSB)vs › | $57.88M | -0.64 | -0.89 | -1.15 | -1.02 |
| Talphera, Inc. (TLPH)vs › | $58.13M | -0.32 | -0.42 | 0.90 | -1.96 |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.94M | -2.39 | -2.92 | -5.17 | -5.77 |
| Connect Biopharma Holdings Limited (CNTB)vs › | $57.69M | N/A | -0.64 | -4.21 | -9.38 |
| Adicet Bio, Inc. (ACET)vs › | $58.97M | N/A | -19.12 | -29.60 | -38.42 |
| Fractyl Health, Inc. (GUTS)vs › | $60.02M | -13.20 | -15.24 | -17.58 | -15.68 |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.05M | -0.27 | -0.26 | -0.31 | -0.32 |
| OKYO Pharma Limited (OKYO)vs › | $56.02M | N/A | -0.18 | -0.24 | -0.27 |
| Xilio Therapeutics, Inc. (XLO)vs › | $61.02M | -1.64 | -9.73 | -25.86 | -294.77 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
$-2.53
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -2.60 |
| 2024-12-31 | -3.85 |
| 2023-12-31 | -2.22 |
| 2022-12-31 | -2.06 |
| 2021-12-31 | -1.13 |
| 2018-12-31 | -2.93 |
| 2017-12-31 | -3.40 |
| 2016-12-31 | -5.59 |
